Pictet Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Sell |
2,760
-11,572
| -81% | -$2.79M | ﹤0.01% | 1233 |
|
|
2025
Q1 | $3.49M | Buy |
14,332
+1,214
| +9% | +$296K | ﹤0.01% | 843 |
|
|
2024
Q4 | $4.31M | Buy |
13,118
+91
| +0.7% | +$29.9K | ﹤0.01% | 833 |
|
|
2024
Q3 | $4.36M | Sell |
13,027
-1,774
| -12% | -$594K | ﹤0.01% | 819 |
|
|
2024
Q2 | $4.04M | Buy |
14,801
+1,320
| +10% | +$361K | ﹤0.01% | 814 |
|
|
2024
Q1 | $4.66M | Sell |
13,481
-1,138
| -8% | -$394K | 0.01% | 795 |
|
|
2023
Q4 | $4.72M | Buy |
14,619
+4,284
| +41% | +$1.38M | 0.01% | 804 |
|
|
2023
Q3 | $3.7M | Buy |
+10,335
| New | +$3.7M | ﹤0.01% | 830 |
|